Eagle Pharmaceuticals to Present at J.P. Morgan 34th Annual Healthcare Conference

WOODCLIFF LAKE, N.J.--()--Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) announced today that Scott Tarriff, President and Chief Executive Officer, and David Riggs, Chief Financial Officer, will present at the J.P. Morgan 34th Annual Healthcare Conference as follows:

                   
Date: Monday, January 11, 2016
 
Time: 11:30 a.m. Pacific Standard Time
 
Location: Westin St. Francis Hotel, San Francisco
 

The presentation will be webcast live at the aforementioned time, and archived for 90 days thereafter, via the company’s website at www.eagleus.com, under the Investors Section and is also available at http://jpmorgan.metameetings.com/confbook/healthcare16/directlink?p=20054.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at www.eagleus.com.

Contacts

In-Site Communications, Inc.
Lisa M. Wilson, 212-452-2793
President

Contacts

In-Site Communications, Inc.
Lisa M. Wilson, 212-452-2793
President